4.7 Article

Electroresponsive Silk-Based Biohybrid Composites for Electrochemically Controlled Growth Factor Delivery

Journal

PHARMACEUTICS
Volume 12, Issue 8, Pages -

Publisher

MDPI
DOI: 10.3390/pharmaceutics12080742

Keywords

growth factor; stimuli-responsive delivery; nerve repair; conductivity; biohybrid; silk; reduced graphene oxide

Funding

  1. Engineering and Physical Sciences Research Council (EPSRC) Doctoral Training Partnership (DTP) via The University of Manchester [EP/N509565/1, 1786315]
  2. Agency for Science, Technology and Research (A*STAR) via the A*STAR Research Attachment Programme (ARAP)
  3. EPSRC National Productivity Investment Fund (NPIF) grant [EP/R512564/1, 2065445]
  4. EPSRC [EP/R003823/1]
  5. Biotechnology and Biological Sciences Research Council (BBSRC) Networks in Industrial Biotechnology and Bioenergy (NIBB) FoodWasteNet (FWN) Proof of Concept Grant [BB/L0137971/1]
  6. Royal Society Research Grant [RG160449]
  7. EPSRC [EP/P025021/1, EP/R003823/1, 1786315, EP/S019367/1] Funding Source: UKRI

Ask authors/readers for more resources

Stimuli-responsive materials are very attractive candidates for on-demand drug delivery applications. Precise control over therapeutic agents in a local area is particularly enticing to regulate the biological repair process and promote tissue regeneration. Macromolecular therapeutics are difficult to embed for delivery, and achieving controlled release over long-term periods, which is required for tissue repair and regeneration, is challenging. Biohybrid composites incorporating natural biopolymers and electroconductive/active moieties are emerging as functional materials to be used as coatings, implants or scaffolds in regenerative medicine. Here, we report the development of electroresponsive biohybrid composites based onBombyx morisilkworm fibroin and reduced graphene oxide that are electrostatically loaded with a high-molecular-weight therapeutic (i.e., 26 kDa nerve growth factor-beta (NGF-beta)). NGF-beta-loaded composite films were shown to control the release of the drug over a 10-day period in a pulsatile fashion upon the on/off application of an electrical stimulus. The results shown here pave the way for personalized and biologically responsive scaffolds, coatings and implantable devices to be used in neural tissue engineering applications, and could be translated to other electrically sensitive tissues as well.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available